A Phase II Study of the Menin Inhibitor Revumenib in Leukemia Associated With Upregulation of HOX Genes
for Leukemia
Drug: Revumenib
Sites in Houston +1 more location
Sponsor: M.D. Anderson Cancer Center
Sex: All·Age: 12+
Code: NCT06229912·Phase 2·Recruiting·Listed Jan 2024